Jasper Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JSPR and other ETFs, options, and stocks.

About JSPR

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation.

CEO

Ronald A. Martell

CEORonald A. Martell

Employees

Employees64

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2018

Founded2018

Employees

Employees64

JSPR Key Statistics

Market cap

86.38M

Market cap86.38M

Price-Earnings ratio

-1.06

Price-Earnings ratio-1.06

Dividend yield

—

Dividend yield—

Average volume

486.62K

Average volume486.62K

High today

$6.10

High today$6.10

Low today

$5.50

Low today$5.50

Open price

$5.51

Open price$5.51

Volume

412.74K

Volume412.74K

52 Week high

$26.05

52 Week high$26.05

52 Week low

$3.13

52 Week low$3.13

Analyst ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own JSPR. This list is generated using Robinhood data, and it’s not a recommendation.